Management of lower respiratory tract infections (LRTI's): clinical microbiologists' perspective

Abstract

In the era of emergence and re-emergence of newer and existing microorganisms, clinical and laboratory diagnosis of LRTI's requires regular evaluation. Elaborating on possible predisposing factors will be critical to health care workers in the better management of patients suffering with Lower Respiratory Tract Infections (LRTI's). Microbiologist's role becomes crucial in deciding the culture methods to be employed to isolate the suspected causative microorganism and identification of the probable pathogen among mixed growth of the isolated bacteria/fungi. Antimicrobial therapy should necessarily be guided by the susceptibility patterns of various antibiotics against different microorganisms from a given geographical region, which should be regularly updated.

The Impact of Fine Particulate Matters (PM10, PM2.5) from Incense Smokes on the Various Organ Systems: A Review of an Invisible Killer

“…Moreover, as per the latest WHO reports, nearly 3.8 million deaths are due to exposure to indoor smoke from cooking fuels. The majority of deaths are due to lower respiratory tract infection (LRTI), [ 3,4 ] upper respiratory tract infection (URTI), cancers associated with the trachea, bronchi, and lung, ischemic heart stroke, stroke, and chronic obstructive pulmonary disease (COPD). [ 5 ] According to the reports, people are exposed to both outdoor and indoor air pollution and mortality associated with this is more than any other disease.…”